Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Stoletov K, Bond D, Hebron K, Raha S, Zijlstra A, Lewis JD.

Am J Clin Exp Urol. 2014 Apr;2(1):45-56.

PMID:
25360439
[PubMed]
Free PMC Article
2.

Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy.

Zhang YY, Zhang ZG, Yu YL, Chen YC, Ni KX, Wang MC, Zhao WP, Rehman F, Wan SP, Li GH.

J Zhejiang Univ Sci B. 2014 Aug;15(8):756-60. doi: 10.1631/jzus.B1400100.

PMID:
25091995
[PubMed - in process]
Free PMC Article
3.

Effect of androgen deprivation therapy on cardiovascular risk factors in prostate cancer.

Roayaei M, Ghasemi S.

J Res Med Sci. 2013 Jul;18(7):580-2.

PMID:
24516490
[PubMed]
Free PMC Article
4.

Biomarkers in prostate cancer surveillance and screening: past, present, and future.

Cary KC, Cooperberg MR.

Ther Adv Urol. 2013 Dec;5(6):318-29. doi: 10.1177/1756287213495915. Review.

PMID:
24294290
[PubMed]
Free PMC Article
5.

The impact of technology diffusion on treatment for prostate cancer.

Schroeck FR, Kaufman SR, Jacobs BL, Zhang Y, Weizer AZ, Montgomery JS, Gilbert SM, Strope SA, Hollenbeck BK.

Med Care. 2013 Dec;51(12):1076-84. doi: 10.1097/MLR.0000000000000019.

PMID:
24226306
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.

Solanki AA, Liauw SL.

Open Access J Urol. 2011 Jun 15;3:95-104. doi: 10.2147/OAJU.S14245. Review.

PMID:
24198641
[PubMed]
Free PMC Article
7.

Controversies on individualized prostate cancer care: gaps in current practice.

Joniau S, Pfister D, de la Taille A, Gaboardi F, Thompson A, Ribal MJ.

Ther Adv Urol. 2013 Oct;5(5):233-44. doi: 10.1177/1756287213490053.

PMID:
24082918
[PubMed]
Free PMC Article
8.

Focal low-dose rate brachytherapy for the treatment of prostate cancer.

Tong WY, Cohen G, Yamada Y.

Cancer Manag Res. 2013 Sep 13;5:315-25. doi: 10.2147/CMAR.S33056. eCollection 2013. Review.

PMID:
24049459
[PubMed]
Free PMC Article
9.

Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging.

Makarov DV, Loeb S, Ulmert D, Drevin L, Lambe M, Stattin P.

J Natl Cancer Inst. 2013 Sep 4;105(17):1306-13. doi: 10.1093/jnci/djt175. Epub 2013 Jul 23.

PMID:
23853055
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A new approach to understanding racial disparities in prostate cancer treatment.

Presley CJ, Raldow AC, Cramer LD, Soulos PR, Long JB, Yu JB, Makarov DV, Gross CP.

J Geriatr Oncol. 2013 Jan;4(1):1-8.

PMID:
23828723
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Focal therapy for prostate cancer: rationale and treatment opportunities.

Kasivisvanathan V, Emberton M, Ahmed HU.

Clin Oncol (R Coll Radiol). 2013 Aug;25(8):461-73. doi: 10.1016/j.clon.2013.05.002. Epub 2013 Jun 4. Review.

PMID:
23759249
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.

Farioli A, Violante FS, Mattioli S, Curti S, Kriebel D.

Cancer Causes Control. 2013 Aug;24(8):1535-45. doi: 10.1007/s10552-013-0230-0. Epub 2013 May 24.

PMID:
23702885
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.

Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS; Canary Prostate Active Surveillance Study Investigators.

Clin Cancer Res. 2013 May 1;19(9):2442-50. doi: 10.1158/1078-0432.CCR-12-3283. Epub 2013 Mar 20.

PMID:
23515404
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?

Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL.

Radiology. 2013 Jul;268(1):144-52. doi: 10.1148/radiol.13121325. Epub 2013 Mar 6.

PMID:
23468576
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prostate cancer screening and the management of clinically localized disease.

Wilt TJ, Ahmed HU.

BMJ. 2013 Jan 29;346:f325. doi: 10.1136/bmj.f325. Review. No abstract available.

PMID:
23360718
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Long-term tumor control after brachytherapy for base-of-prostate cancer.

Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ.

J Contemp Brachytherapy. 2011 Dec;3(4):183-7. doi: 10.5114/jcb.2011.26468. Epub 2011 Dec 30.

PMID:
23346126
[PubMed]
Free PMC Article
17.

Focal cryosurgical ablation of the prostate: a single institute's perspective.

Hale Z, Miyake M, Palacios DA, Rosser CJ.

BMC Urol. 2013 Jan 11;13:2. doi: 10.1186/1471-2490-13-2.

PMID:
23311921
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Quality of life in men undergoing active surveillance for localized prostate cancer.

Bergman J, Litwin MS.

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):242-9. doi: 10.1093/jncimonographs/lgs026.

PMID:
23271780
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.

Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J, Kanao K, Goldman DA, Moskowitz CS, Reuter VE, Eastham JA, Scardino PT, Hricak H.

Radiology. 2012 Nov;265(2):478-87. doi: 10.1148/radiol.12120041. Epub 2012 Sep 5.

PMID:
22952382
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk